Search
Login
Register
Menu
Latest issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Ixazomib: the first oral proteasome inhibitor for the treatment of multiple myeloma
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Ixazomib: the first oral proteasome inhibitor for the treatment of multiple myeloma
€
3.03
Article: Ixazomib: the first oral proteasome inhibitor for the treatment of multiple myeloma quantity
Add to cart
SKU:
product-article-16219
Category:
General
Description
Description
Ixazomib: the first oral proteasome inhibitor for the treatment of multiple myeloma
Related products
Article: Highlights in squamous cell carcinoma of the head and neck
€
3.03
Add to cart
Article: Highlights in gynaecological cancers
€
3.03
Add to cart
Article: INTRODUCTION
€
3.03
Add to cart
Article: INTRODUCTION
€
3.03
Add to cart